Mike Sinn, CureDAO/Quantimodo
I got my degree in Electrical Engineering and Physics. Then I spent a decade doing industrial root-cause failure analysis and managing a testing lab. During that time, I developed several conditions like arthritis, psoriasis, and depression. I was sent to a specialist for each condition. However, after many years I was still miserable, so I decided to start applying the same techniques that we used at my lab to identify the root cause of my symptoms. So, I started tracking symptoms and potential...
Mac Davis, Minicircle
Founder of Minicircle. Gene therapy promises unlimited health, independence from disease, and for us to creatively rewrite the future of our identity. My life is dedicated to the liberation of humanity from suffering and enhancing the sovereignty of all individuals and communities by means of making safe and accessible plasmid gene therapy available to all. I founded my company Minicircle as a method development company with the purpose of designing and commercializing the world's first reversible...
Anastasia Egorova, Open Longevity
Co-founder and co-CEO at Open Longevity, Vice-President of Science for Life Extension Foundation. Transhumanist and social entrepreneur.
What is the most undervalued area for longevity progress we should pursue?
Altering regulation around drug approval to accelerate drug development in the longevity space.
Where are we today? Where would we like to be?
Rapid drug development led to a massive increase in life expectancy in the early 1900’s. After the Thalidomide disaster, the FDA clamped down on drug development and reduced new treatments by 70%. The average cost per drug has skyrocketed in the past decades.
What public and private actions have the biggest impact on those goals?
Building an alternative structure to the FDA
What people, funding, resources, experiments would be required to test this hypothesis?
An open source framework, willing participants, and most importantly an economically free zone outside of FDA jurisdiction are required to test this concept.